Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

News Daily News

Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL

Michael O'Riordan

February 15, 2023

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Caitlin E. Cox

November 11, 2022

News Opinion Fellow Talk

Don’t Expect Success in Interventional Cardiology, Prepare for It!

Yuvraj S. Chowdhury, MD

February 24, 2022

Presentation TCT 2021

Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction

Presenter: Ankur Kalra

November 04, 2021

News Opinion Fellow Talk

Top Five Online Resources for Fellows Pursuing Interventional Cardiology

Kris Kumar, DO

October 28, 2021

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

Presentation TCT 2021

Invasive versus Medical Management In Patients with Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction

Presenter: Ankur Kalra

October 20, 2021

News Daily News

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

Michael O'Riordan

September 20, 2021

Presentation TVT 2021

Valve-in-Valve TAVR vs Reoperative SAVR in Patients With Failed Aortic Bioprosthesis: Insight from Nationwide Readmission Database

Presenter: Ankur Kalra

July 22, 2021

News Daily News

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

Caitlin E. Cox

July 06, 2021

News Opinion Off Script

From the Dress Rehearsal to Closing Night: Lessons in Humility and Hope

Ankur Kalra

June 15, 2021

News Daily News

Women Making Strides as First Authors of Cardiology Trials

L.A. McKeown

March 09, 2021

News Conference News CRT 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

Todd Neale

March 08, 2021

News Daily News

Unplanned PCI Rare After TAVI, but Operators Get Good Results

Michael O'Riordan

January 18, 2021

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Michael O'Riordan

December 21, 2020

News Daily News

Stress Cardiomyopathy Up in Ohio—but Not Directly Due to COVID-19

Yael L. Maxwell

July 13, 2020

News Daily News

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

L.A. McKeown

June 08, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Conference News AHA 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

Caitlin E. Cox

November 17, 2019

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

Advertisement

Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Don’t Expect Success in Interventional Cardiology, Prepare for It!

Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction

Top Five Online Resources for Fellows Pursuing Interventional Cardiology

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Invasive versus Medical Management In Patients with Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

Valve-in-Valve TAVR vs Reoperative SAVR in Patients With Failed Aortic Bioprosthesis: Insight from Nationwide Readmission Database

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

From the Dress Rehearsal to Closing Night: Lessons in Humility and Hope

Women Making Strides as First Authors of Cardiology Trials

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

Unplanned PCI Rare After TAVI, but Operators Get Good Results

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Stress Cardiomyopathy Up in Ohio—but Not Directly Due to COVID-19

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

More Adverse Events, Higher Costs With Impella: New Observational Studies

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content